Bertil Uggla

1.6k total citations
31 papers, 1.1k citations indexed

About

Bertil Uggla is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Bertil Uggla has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 12 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Bertil Uggla's work include Acute Myeloid Leukemia Research (16 papers), Retinoids in leukemia and cellular processes (7 papers) and Acute Lymphoblastic Leukemia research (6 papers). Bertil Uggla is often cited by papers focused on Acute Myeloid Leukemia Research (16 papers), Retinoids in leukemia and cellular processes (7 papers) and Acute Lymphoblastic Leukemia research (6 papers). Bertil Uggla collaborates with scholars based in Sweden, Australia and France. Bertil Uggla's co-authors include Ulf Tidefelt, Gunnar Juliusson, Sören Lehmann, Christer Paul, Per‐Ola Andersson, Martin Höglund, Dina Ali, Ali Moshfegh, Klas G. Wiman and Honar Cherif and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Bertil Uggla

30 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bertil Uggla Sweden 14 600 485 414 195 162 31 1.1k
Michal Bar‐Natan United States 15 719 1.2× 524 1.1× 312 0.8× 364 1.9× 98 0.6× 41 1.3k
Chetasi Talati United States 16 592 1.0× 512 1.1× 247 0.6× 326 1.7× 88 0.5× 78 1.1k
Lauren E. Damon United States 12 782 1.3× 536 1.1× 199 0.5× 401 2.1× 111 0.7× 21 1.2k
Joan Besalduch Spain 20 868 1.4× 464 1.0× 408 1.0× 327 1.7× 316 2.0× 44 1.4k
Anuj Mahindra United States 17 918 1.5× 703 1.4× 477 1.2× 227 1.2× 57 0.4× 56 1.2k
Devendra Hiwase Australia 20 944 1.6× 378 0.8× 296 0.7× 489 2.5× 103 0.6× 107 1.3k
Maria Kleppe United States 13 361 0.6× 459 0.9× 230 0.6× 302 1.5× 118 0.7× 24 947
Simon Bomken United Kingdom 13 234 0.4× 376 0.8× 366 0.9× 93 0.5× 202 1.2× 32 964
Oliver Galm Germany 23 602 1.0× 1.5k 3.0× 436 1.1× 231 1.2× 100 0.6× 51 2.0k
S. Faderl United States 16 882 1.5× 417 0.9× 240 0.6× 393 2.0× 214 1.3× 24 1.2k

Countries citing papers authored by Bertil Uggla

Since Specialization
Citations

This map shows the geographic impact of Bertil Uggla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bertil Uggla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bertil Uggla more than expected).

Fields of papers citing papers by Bertil Uggla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bertil Uggla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bertil Uggla. The network helps show where Bertil Uggla may publish in the future.

Co-authorship network of co-authors of Bertil Uggla

This figure shows the co-authorship network connecting the top 25 collaborators of Bertil Uggla. A scholar is included among the top collaborators of Bertil Uggla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bertil Uggla. Bertil Uggla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deneberg, Stefan, Bertil Uggla, Austin Smith, et al.. (2024). A Phase I/II Study Investigating Karonudib in Patients with Refractory Haematological Malignancies. Blood. 144(Supplement 1). 6010–6010. 1 indexed citations
2.
3.
Eriksson, Anna, Martin Jädersten, Vladimir Lazarević, et al.. (2022). A risk score based on real-world data to predict early death in acute promyelocytic leukemia. Haematologica. 107(7). 1528–1537. 12 indexed citations
4.
Lidén, Mats, et al.. (2021). Quantitative T2* imaging of iron overload in a non-dedicated center – Normal variation, repeatability and reader variation. European Journal of Radiology Open. 8. 100357–100357. 6 indexed citations
5.
Vaht, Krista, Magnus Göransson, Kristina Carlson, et al.. (2019). High Graft-versus-Host Disease-Free, Relapse/Rejection-Free Survival and Similar Outcome of Related and Unrelated Allogeneic Stem Cell Transplantation for Aplastic Anemia: A Nationwide Swedish Cohort Study. Biology of Blood and Marrow Transplantation. 25(10). 1970–1974. 8 indexed citations
6.
Vaht, Krista, Magnus Göransson, Kristina Carlson, et al.. (2018). Low response rate to ATG‐based immunosuppressive therapy in very severe aplastic anaemia — A Swedish nationwide cohort study. European Journal Of Haematology. 100(6). 613–620. 14 indexed citations
7.
Lehmann, Sören, Stefan Deneberg, P Antunović, et al.. (2017). Early death rates remain high in high-risk APL: update from the Swedish Acute Leukemia Registry 1997–2013. Leukemia. 31(6). 1457–1459. 40 indexed citations
8.
Vaht, Krista, Magnus Göransson, Kristina Carlson, et al.. (2017). Incidence and outcome of acquired aplastic anemia: real-world data from patients diagnosed in Sweden from 2000–2011. Haematologica. 102(10). 1683–1690. 61 indexed citations
9.
Vaht, Krista, Magnus Göransson, Kristina Carlson, et al.. (2016). Incidence and Outcome in Aplastic Anemia Diagnosed 2000-2011 - a Nationwide Swedish Registry Study. Blood. 128(22). 3905–3905. 1 indexed citations
10.
Lazarević, Vladimir, Aldana Rosso, Gunnar Juliusson, et al.. (2015). Prognostic significance of high hyperdiploid and triploid/tetraploid adult acute myeloid leukemia. American Journal of Hematology. 90(9). 800–805. 14 indexed citations
11.
Mulligan, Stephen P., Karin Karlsson, Viggo Jønsson, et al.. (2014). Cladribine prolongs progression-free survival and time to second treatment compared to fludarabine and high-dose chlorambucil in chronic lymphocytic leukemia. Leukemia & lymphoma. 55(12). 2769–2777. 13 indexed citations
12.
Burman, Joachim, Ellen Iacobaeus, Anders Svenningsson, et al.. (2014). Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience. Journal of Neurology Neurosurgery & Psychiatry. 85(10). 1116–1121. 118 indexed citations
13.
Lazarević, Vladimir, Bertil Johansson, P Antunović, et al.. (2014). Incidence and prognostic significance of karyotypic subgroups in older patients with acute myeloid leukemia: the Swedish population-based experience. Blood Cancer Journal. 4(2). e188–e188. 41 indexed citations
14.
Lazarević, Vladimir, Bertil Johansson, Petar Antunović, et al.. (2014). Failure matters: unsuccessful cytogenetics and unperformed cytogenetics are associated with a poor prognosis in a population‐based series of acute myeloid leukaemia. European Journal Of Haematology. 94(5). 419–423. 11 indexed citations
15.
Uggla, Bertil & Torbjörn Nilsson. (2014). Whole blood viscosity in plasma cell dyscrasias. Clinical Biochemistry. 48(3). 122–124. 9 indexed citations
16.
Uggla, Bertil, Stefan Deneberg, Sofia Bengtzén, et al.. (2009). Low p14ARF expression in de novo acute myeloid leukemia with normal karyotype is associated with poor survival. Leukemia & lymphoma. 50(9). 1512–1518. 4 indexed citations
17.
Uggla, Bertil, et al.. (2009). Rapid induction of P-glycoprotein mRNA and protein expression by cytarabine in HL-60 cells.. PubMed. 29(10). 4071–6. 14 indexed citations
18.
Uggla, Bertil, Elisabet Tina, Hareth Nahi, et al.. (2007). Topoisomerase IIα mRNA and protein expression vs. in vitro drug resistance and clinical outcome in acute leukaemia. International Journal of Oncology. 31(1). 153–60. 2 indexed citations
19.
Uggla, Bertil, Dick Wågsäter, Christer Paul, et al.. (2004). BCRP mRNA expression v. clinical outcome in 40 adult AML patients. Leukemia Research. 29(2). 141–146. 87 indexed citations
20.
Uggla, Bertil, et al.. (2001). Expression of topoisomerase IIα in the G0/G1 cell cycle phase of fresh leukemic cells. Leukemia Research. 25(11). 961–966. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michal Bar‐Natan Breakdown of academic impact, for papers by Chetasi Talati Breakdown of academic impact, for papers by Lauren E. Damon Breakdown of academic impact, for papers by Joan Besalduch Breakdown of academic impact, for papers by Anuj Mahindra Breakdown of academic impact, for papers by Devendra Hiwase Breakdown of academic impact, for papers by Maria Kleppe Breakdown of academic impact, for papers by Simon Bomken Breakdown of academic impact, for papers by Oliver Galm Breakdown of academic impact, for papers by S. Faderl
Rankless by CCL
2026